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The emergence of the interdisciplinary field of salivary bioscience has created opportunity
for neonatal researchers to measure multiple components of biological systems non-
invasively in oral fluids. The implications are profound and potentially high impact. From
a single oral fluid specimen, information can be obtained about a vast array of biological
systems (e.g., endocrine, immune, autonomic nervous system) and the genetic polymor-
phisms related to individual differences in their function. The purpose of this review is
to describe the state of the art for investigators interested in integrating these unique
measurement tools into the current and next generation of research on gonadal steroid
exposure during the prenatal and neonatal developmental periods.
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INTRODUCTION
The direction of research in the field of human development is
being influenced by theoretical models that champion the study
of individual differences using multi-level analyses of the con-
fluence of prenatal, biological, behavioral, and social contextual
forces [e.g., Ref. (1–4)]. Only recently have advances in salivary
bioscience enabled investigators to test some of the core theoret-
ical assumptions directly. Technical innovations now reveal that
information may be obtained from oral fluid specimens about a
broad array of physiologic systems including adrenal and gonadal
steroids, inflammatory proteins of various types, infectious disease
antibodies, environmental chemical exposures, metabolic mark-
ers, and genetic variability relevant to basic biological function,
health, and disease. The attention that saliva has received as a
biospecimen is largely due to the perceptions of sample collection
as quick, uncomplicated, cost-efficient, and safe, and of salivary
assays as reliable and accurate (see Table 1). The purpose of this
report is to provide a roadmap for investigators interested in push-
ing cutting-edge integration of these measurement tools into the
next generation of studies on gonadal steroid exposure and child
development.
To date, the range of salivary analytes that have been inte-
grated into developmental science has been restricted relative to
the possibilities. The majority of studies with infants and chil-
dren have primarily targeted cortisol as the salivary marker of
choice given known associations with prenatal exposure [e.g.,
Ref. (5)], child behavior [e.g., Ref. (6, 7)], and in following
with developmental origins theory, that early calibration of
stress systems impacts health and development across the life
course (8). However, the salivary proteome contains more than
1000 detectable analytes (9), including more understudied out-
puts of the hypothalamic–pituitary–gonadal (HPG) axis. Saliva
contains measurable estrogens, androgens, and progesterone, yet
few studies have collected oral fluid for this purpose in women
during the antepartum and postpartum periods or in neonates
(see Table 2); most have relied on serum.
The extant literature on gonadal steroids focuses largely on lev-
els observed during puberty and adulthood [see reviews (30, 31)];
we know far less about gonadal steroid exposure in early life
and the majority of studies have relied on quantification from
serum or plasma. However, not only do gonadal steroids of mater-
nal origin cross the placental barrier and target the developing
fetal brain (32, 33), but also birth marks a significant hormonal
transition as the influence of the maternal endocrine milieu is
withdrawn. In the first month following birth, infants exhibit a
postnatal surge in gonadal steroids that parallel levels reached in
adolescence, referred to as“mini-puberty”(34, 35). Further, steroid
levels found in saliva, albeit lower in concentration, are correlated
with serum constituents, particularly the free fraction which exerts
physiological effects (12, 36).
To this end, we propose measurement considerations for oral
fluid and applications of salivary analytes in studies of maternal
and neonatal gonadal steroid activity for future investigation.
SALIVARY MEASUREMENT CONSIDERATIONS
PRIMER ON ORAL FLUID AS A BIOSPECIMEN
“Saliva” is a composite of oral fluids secreted from many differ-
ent glands. The source glands are located in the upper posterior
area of oral cavity, lower area of the mouth between the cheek and
jaw, and under the tongue. There are also many minor secretory
glands in the lip, cheek, tongue, and palate. A small fraction of oral
fluid (crevicular fluid) also comes from serum leakage in the cleft
area between each tooth and its surrounding gums, or via leak-
age from serum due to mucosal injury or inflammation. Under
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healthy conditions, the contribution from serum is minimal but
under conditions of mucosal or epithelial inflammation, serum
constituents can represent a substantial portion of the analytes
in the oral fluid pool. Each secretory gland produces a fluid that
differs in volume, composition, and constituents [e.g., Ref. (37)].
Each source gland’s contribution to the pool of oral fluid varies
(38). Oral fluid is water-like in composition and has a pH (acidity)
range between 6 and 9. Foods and substances placed in the mouth
are capable of changing specimen acidity because oral fluid has
Table 1 | Perceived “advantages” of oral fluids as a research specimen.
“Minimally invasive” Considered “acceptable and non-invasive” by
research participants and patients
Collection is quick, non-painful, uncomplicated
“Safety” Reduces transmission of infectious disease by
eliminating the potential for accidental needle
sticks
CDC does not consider saliva a class II biohazard
unless visibly contaminated with blood
“Self-collection” Allows for community- and home-based collection
Enables specimen collection in special populations
“Economics” Eliminates the need for a health care intermediary
(e.g., phlebotomist, nurse)
Resources for collection and processing samples
are low cost and available
“Accuracy” Salivary levels of many analytes represent the
“free unbound fraction” or biological active fraction
in the general circulation
minimal buffering capacity. These changes in sample integrity have
been shown to compromise measurement validity [e.g., Ref. (39)].
Gonadal hormones are exemplars of salivary analytes that
reflect levels in general circulation, otherwise known as serum
constituents. Serum constituents are transported into saliva either
by filtration between the tight spaces between cells in the sali-
vary glands or diffusion through cell membranes thereby enabling
investigators to make interferences about systemic physiological
states. Other analytes found in oral fluids are synthesized, stored,
and released from the granules within the secretory cells of the
saliva glands (i.e., enzymes, mucins, cystatins, histatins). Still oth-
ers are components of humoral (antibodies, complement) immu-
nity or compounds (cytokines) secreted by cells (neutrophils,
macrophages, lymphocytes) of the mucosal immune system. An
understanding of whether an analyte is transported into oral fluid
by filtration or passive diffusion, secreted from salivary glands, or
released or derived from cells locally in the oral mucosa is key to
interpreting the meaning of individual differences in that measure.
The secretion of oral fluids is influenced by the day–night cycle;
chewing movement of the mandibles; taste and smell; iatrogenic
effects of medications that cause xerostomia (dry mouth); as well
as medical interventions and conditions that affect saliva gland
function. Saliva glands are directly innervated by parasympathetic
and sympathetic nerves (40). Not surprisingly, activation of the
ANS component of the psychobiology of the stress response affects
saliva flow rates. The levels of salivary analytes that migrate into
saliva from blood by filtration through the junctions between
cells in the salivary gland (e.g., dehydroepiandrosterone-sulfate
and other conjugated steroids) are influenced by the rate of saliva
secretion [e.g., Ref. (41)].
The U.S. Centers for Disease Control notes that unless visibly
contaminated with blood, oral fluid is not a class II biohazard.
This statement has contributed to the perception that, among
behaviorally scientists, saliva is safer to work with than blood. In
Table 2 | Gonadal steroid salivary analytes of interest to developmental science and past human studies utilizing salivary assessment in the
prenatal and neonatal periods.
Study population Reference
Antepartum women Postpartum women Neonates
ESTROGENS
Estradiol x x (10–12)
Esterone x x (10–12)
Estriol x x (10–20)
ANDROGENS
Testosterone x x x (11, 12, 21)
Dehydroepiandrosterone and -sulfate x x (12)
Androstenedionea
PROGESTAGENS
Progesterone; 17-OH progesterone x x x (10, 12, 15, 16, 20, 22–24)
Aldosterone x (25)
Sources to generate list of gonadal steroid analytes:Tabak (26); Malamud andTabak (27); Cone and Huestis (28); U.S. Department of Health and Human Services (29).
aTo our knowledge, past studies have exclusively sampled plasma androstenedione; no studies to date have indexed salivary androstenedione in women during the
antepartum or postpartum periods or in neonates.
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reality, even under normative-healthy conditions, more than 250
species of bacteria are present in oral fluids (42). During upper res-
piratory infections, oral fluids are highly likely to contain agents
of disease (43). An informal survey of biosafety policies at North
American and UK academic institutions reveals a consensus that
oral fluid specimens should be handled with universal precautions
when employed for use in research or diagnostic applications.
SAMPLE COLLECTION
In the past, saliva collection devices have involved cotton-based
absorbent materials [e.g., Ref. (44, 45)]. Placed in the mouth for
2–3 min, oral fluids rapidly saturate the cotton; the specimen is
expressed into collection vials by centrifugation or compression
[e.g., Ref. (46)]. Most of the time, this approach is convenient,
simple, and time-efficient. However, when the absorbent capacity
is large and sample volume is small, as is the case for neonates,
the specimen absorbed can be diffusely distributed in the cotton
fibers, making sample recovery problematic [e.g., Ref. (47)]. The
process of absorbing oral fluid with cotton, and other materials,
also has the potential to interfere with the immunoassay of several
salivary analytes (48, 49).
Early studies with neonates employed serum assays modi-
fied for use with saliva by, among other things, requiring large
saliva test volumes (200–400µl). To collect sufficient test volumes,
saliva flow was often stimulated using techniques that involved
tasting (sugar crystals, citric acid drops) substances. When not
used minimally and/or consistently, some of these methods are
capable of changing immunoassay performance [e.g., Ref. (39)].
Indirectly, stimulants also influence measurement of the lev-
els of salivary analytes that are dependent on saliva flow rate
(dehydroepiandrosterone-sulfate, DHEA-S). Saliva collected from
neonates requires a technique that uses an absorbent material
(50). Current collection methods use oral swabs, which are ideal
for neonates and infants. This is because the swab can be nar-
rower in diameter, particularly well-suited for the small mouths of
neonates, and the material is non-toxic and durable for use with
older infants that may gum the device during collection.
SAMPLE HANDLING, TRANSPORT, AND STORAGE
Typically, once specimens are collected, they should be kept cold or
frozen. Refrigeration prevents degradation of some salivary ana-
lytes and restricts the activity of proteolytic enzymes and growth
of bacteria. We explored the impact of bacteria-related issues on
the measurement of salivary analytes. Significant declines occur in
the levels of some salivary analytes when samples are stored at RT
or 4°C in comparison to −60°C after 96 h (51). Whembolua and
colleagues (52) showed that changes in salivary analytes related to
storage temperatures were associated with growth in bacteria, but
not baseline bacteria levels. The way in which samples are handled,
stored, and transported after collection has the potential to influ-
ence sample integrity and measurement validity. Our recommen-
dation is conservative. After collection, saliva samples should be
kept frozen. If freezing is not possible, then at a minimum, samples
should be kept cold (on ice or refrigerated) until they can be frozen
that day. Repeated freeze–thaw cycles should be avoided with saliva
samples. In our experience, DHEA, estradiol, and progesterone are
very sensitive to freeze–thaw, whereas testosterone is robust (up to
at least three cycles). This position is consistent with aliqouting
and archiving frozen samples in anticipation that biotechnol-
ogy advances will enable different markers to be assayed in the
future. It should also be noted that some salivary analytes may
require specimens to be directly collected into storage vials that
are chilled [Ref. (53); but see Ref. (54)] or treated with neuropep-
tidase inhibitors (such as EDTA or aprotinin) to minimize rapid
degradation (55, 56). For large-scale national surveys, investigators
working in remote areas [e.g., Ref. (57, 58)], or patients collecting
samples at home (59), freezing and shipping these frozen samples
can be logistically complex and cost-prohibitive. Under special
circumstances, saliva may not be the biospecimen of choice; alter-
natively, the degree of the impact of the handling and storage
conditions should be documented by pilot work.
CONTAMINANTS IN ORAL FLUID
Most of the time, to meaningfully index systemic biological activ-
ity, quantitative estimates of an analyte (e.g., hormone) in saliva
must be highly correlated with the levels measured in serum. The
magnitude of this serum–saliva association depends, in part, on
consistency in the processes (27) used to transport circulating mol-
ecules into oral fluids. When the integrity of diffusion or filtration
is compromised, the level of the serological marker in saliva will
be affected because of the differential concentration gradient. It
also depends on the presence of contaminants in oral fluid, which
investigators should be aware of, control for if possible, and in all
cases, document.
Blood and blood products can leak into oral fluids via burns,
abrasions, or cuts to the cheek, tongue, or gums. Blood in oral fluid
is more prevalent among individuals who suffer from poor oral
health (i.e., open sores, periodontal disease, gingivitis), endure cer-
tain infectious diseases [e.g., HIV; Ref. (60)], and engage in behav-
ior known to influence oral health negatively [e.g., tobacco use;
Ref. (61)]. Saliva contaminated with blood will present varying
degrees of yellow-brownish hue (62). Utilizing salivary transfer-
rin as a surrogate marker, our bench (spiking blood into saliva)
and experimental studies (inducing microinjury to the mouth by
brushing the gums) have shown the degree of blood contami-
nation needed to influence salivary hormone levels. Differences
among the lengths of the effect (10–45 min) depend on the salivary
analyte of interest (62–64). Gonadal steroids appear to be more
susceptible to blood leakage in the oral cavity, with testosterone
in particular showing an increase in response to microinjury in
the oral cavity (62). At the same time,<0.1% of statistical outliers
(+2.5 SDs) in salivary hormone distributions have been shown to
be associated with elevated transferrin (65). Thus, blood contam-
ination of oral fluid was a characteristic of individual specimens
and not consistently detected within all samples from individuals.
In studies of neonates and children, blood contamination is rare
(65), however, studies of antepartum women who may present oral
health risk should take heed to document and control for blood
contamination.
A more universal concern, and one especially relevant in
neonates, is contamination of samples from particulate matter
and interfering substances placed in the mouth. Breastmilk, for-
mula, and solids introduced later in infancy create residue in the
oral cavity after drinking or eating may include particulate matter,
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change salivary pH or composition (viscosity), and/or contain
substances (e.g., bovine hormones, enzymes) that cross-react in
immune- or kinetic-reaction assays. Given the variation of infant
feeding schedules and the difficulty in restricting intake, partic-
ularly when young infants are fed on demand, we recommend
a simple solution: children should not be fed and adults should
refrain from eating and drink with exception of water within the
20-min prior to sample donation. For repeated measure designs,
saliva collection should be carefully planned and scheduled, and
prior feedings noted.
Prescription and over-the-counter medications are also known
contaminants to oral fluid, including those that are applied
intranasally, inhaled or applied as oral topicals (e.g., teething gels).
These substances have the potential to change saliva composition
due to residue left by their use in the oral cavity, cross-reaction
with antibody–antigen binding in immunoassays, and reduced
salivary flow rate (66, 67). Confounding the effort to control for
the potential effects of medications on salivary analytes is the pos-
sibility that the condition for which the medication is prescribed or
taken may also influence individual differences in the analytes lev-
els or activity (68). Few behaviorally oriented studies that involve
salivary analytes have comprehensively documented medication
usage. In one study of infants, nearly half (44%; n= 852) of the 6-
month-old infants were given acetaminophen in the 48 h prior to
saliva collection. Acetaminophen was shown to attenuate cortisol
reactivity (69); implications for gonadal steroids remain unknown.
The lack of normative data and the wide-ranging individual
differences in salivary analytes levels make case-by-case exclu-
sion of samples from individuals taking any particular medication
questionable (unless the deviation is obviously not physiologi-
cally plausible). Of course, the simplest approach would be to
exclude anyone who is taking any medication from participation
in research. This includes sampling from neonates of breastfeeding
mothers who are themselves on a medication. Although appropri-
ate from the perspective of rigorous experimental design, this con-
servative approach yields no information that may help us develop
our knowledge of which medications are, or are not, problematic.
Also, in studies of some specialized populations (e.g., pregnant
patients with physical or mental illnesses),prescription medication
use is so highly prevalent that it is considered normative. With-
holding treatment raises ethical questions while excluding those
taking medications increases the potential that findings may be
confounded by selection bias. Future work is encouraged to doc-
ument participant medication use and evaluate associations with
steroid levels measured in saliva to build knowledge and document
pharmaceutical contamination effects or lack thereof.
APPLICATIONS OF SALIVARY ANALYTES IN STUDIES OF
MATERNAL AND NEONATAL GONADAL STEROID ACTIVITY
Dependent on the nature of the research question, several sam-
pling schemes are common for studies involving oral fluid. At the
individual level, a single sample may be collected to index basal
level, or multiple samples may be collected across the course of the
day to capture diurnal rhythm. Concurrent sampling of a dyad
is an additional scheme designed to evaluate associative relations
over time. In further discussion of each sampling scheme below,
we have embedded existing research drawn from Table 2 utilizing
saliva to index maternal and neonatal gonadal steroid levels to
encourage additional reading. Existing studies are relatively scant,
yet saliva offers a wide array of application as a minimally inva-
sive, accurate, and cost-effective approach; we offer suggestions for
areas of future investigation with salivary analytes.
BASAL OR “TRAIT-LIKE” LEVELS
The basal level or activity of an analyte represents the stable state of
the host during a resting period. One approach to assessing basal
levels has been to sample early in the morning before the events of
the day are able to contribute variation or specify a restricted time
window for collection to reduce variation between participants
[e.g.,±1200 h, Ref. (12)].
Single sampling is the most common approach for saliva col-
lection, and the majority of studies referenced in Table 2 have
employed this scheme. While overall the literature on salivary
steroids during pregnancy and in the postpartum is lacking, stud-
ies examining estriol levels among antepartum women are most
common (see Table 2). Estriol monitoring via saliva has been uti-
lized as a clinical tool to assess the vitality of fetoplacental unit
and a marker of preterm birth (17, 18). For this analyte, repeated
measures of the “basal” level have been employed to detect atyp-
ical change [e.g., Ref. (18); weekly sampling from 22 weeks GA
until birth]. As seen, the studies by Marrs and colleagues (11) as
well as the more recent Hampson and colleagues (12) offer the
most comprehensive report on gonadal steroids concentrations in
antepartum and postpartum women and in comparison to serum,
though limited to a single measurement during the third trimester
of pregnancy. Future work is needed to elucidate reference val-
ues for gonadal steroids earlier in gestation, to evaluate normative
endocrine changes of pregnancy and serve as a clinical tool for
diagnosis of adrenal disorders during pregnancy.
We are only aware of a single study measuring neonatal salivary
testosterone basal levels; findings revealed a positive association
between salivary testosterone and neonatal health problems as well
as growth delays among a high-risk preterm sample (21). A multi-
tude of studies have explored neonatal cortisol reactivity, but more
research is needed to understand the significance of the gonadal
hormonal transition surrounding birth. Beyond the neonatal
period, a handful of studies have sampled gonadal steroids to char-
acterize “mini-puberty” observed during early infancy (70, 71).
Testosterone levels of male infants peak between 1 and 3 months
of age, and female infants show a spike between 2 and 4 months
in follicle stimulating hormone (71, 72). The physiological rel-
evance of this phenomenon, which exhibits universality across
mammalian species, is theorized to activate sexual dimorphisms
in the brain (72), remains underexplored to date. These analyses
relied on single measures at varying ages to identify peak levels.
While a start, a single-time point measure of salivary ana-
lytes (other than invariant genetic polymorphisms), except under
very unique circumstances, is unlikely to yield meaningful results
for “basal levels” given that salivary analytes may vary depend-
ing on the inherent moment-to-moment, diurnal and/or monthly
variation in their production/release, rate of their metabo-
lism/degradation, and sensitivity to environmental influence.
Given these issues, in combination with the moving target gonadal
steroids present during the antepartum and neonatal/infant
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periods during which physiological shifts in hormone concentra-
tion are expected, cluster sampling for a series of three consecutive
days is recommended. The association of salivary analyte measure-
ments across days is likely to be stronger for some salivary analytes
than others yet employing cluster sampling enhances overall reli-
ability of the estimates by aggregating (e.g., average assay results
or physically pool specimens). The minimally invasive nature of
oral fluid collection is ideal for cluster sampling. Future studies are
needed to describe the observed surge in gonadal steroids during
infancy, investigate sex differences, and test predictive associations
linking gonadal steroid activation to behavior.
DIURNAL RHYTHM
An important component of variability within and between indi-
viduals in salivary analyte levels is the diurnal rhythm of produc-
tion [e.g., Ref. (73, 74)]. Most salivary hormone levels (e.g., cor-
tisol, testosterone) are high in the morning, decline before noon,
and then decline more slowly in the afternoon and evening hours
(75). The non-linear nature of these patterns requires multiple
sampling time points to create adequate statistical models (76).
The diurnal rhythm of gonadal steroid output in antepartum
or postpartum women remains largely unexplored to date. There
is evidence that the diurnal pattern is retained during pregnancy
for other hormone outputs such as cortisol (77–79). For neonates,
recent evidence suggests that in the first postnatal week the adrenal
circadian rhythm becomes unsynchronized with clock time, peak-
ing in late afternoon or at a time parallel to the birth time (80).
The typical 24-h rhythm is generally not observed until after a
few months for cortisol production, potentially coinciding with
stabilization of the sleep–wake cycle. One study of salivary 17-OH
progesterone indexed in neonates on the first or second day of life
confirmed this, finding no evidence of a diurnal pattern (22). In a
second cross sectional study designed to establish diurnal reference
values for salivary progesterone and 17-OH progesterone, a diur-
nal pattern was observed among neonates <4 weeks age (n= 13,
age range= 4–27 days) for 17-OH progesterone but not proges-
terone (23). Less is known about at what age gonadal steroids
begin to show a characteristic diurnal rhythm; future studies doc-
umenting this would represent a considerable contribution to the
literature, particularly during this rapid phase of development.
Analytical techniques that have been used to model individual
differences in diurnal rhythm range from average levels, to focus-
ing specifically on the awakening component of the overall pattern,
to estimating AUC. Growth curve modeling (81) may be an opti-
mal method of parameterizing individual differences because: (1)
it allows the level and slope of the diurnal rhythm to be examined
in the same model; (2) unsystematic error variance is partialed
out of the “true” score; (3) the presence of individual differences
in the diurnal rhythm is statistically tested; (4) predictors of the
diurnal rhythm are related to level and slope in the same model
(partialing out the effects of one another); and (5) changes in the
variance estimates of the level and slope act as indicators of the
overall contribution of the predictors [e.g., Ref. (81, 82)].
ASSOCIATIVE RELATIONS OF SALIVARY ANALYTES BETWEEN DYADS
Physiological attunement or concordance of maternal and fetal
hormones is documented before birth, in utero. For example,
maternal prenatal testosterone serum levels are correlated with
fetal levels ascertained from samples of amniotic fluid for both
sexes (83). Further, women carrying male fetuses show higher
testosterone concentrations relative to those carrying females (84)
suggesting bidirectionality of observed associative relations.
Although recognized that in the postpartum period gonadal
steroids may be decreasing in concentration among women while
concurrently increasing among neonates, postnatal dyadic attune-
ment of gonadal steroids remains an underexplored, yet promis-
ing, avenue for future research. The study noted in Table 2 that
indexed neonatal salivary testosterone did find a positive correla-
tion between testosterone levels in neonates and mothers in the
first week after birth (21). Examining predictive associations from
maternal levels during pregnancy to neonatal levels in the post-
partum would also be of interest; for example, is there a greater
or faster increase in gonadal steroid activity among neonates that
experience more significant withdrawal from the maternal prena-
tal endocrine context (i.e., exposure to higher concentrations in
the prenatal period).
The examination of associative relations need not be con-
strained to the dyad; at the individual level, this scheme carries
over to studies exploring the coaction of two or more hormones.
A single saliva sample of sufficient volume may be assayed for mul-
tiple analytes. For example, there is known functional cross-talk
occurring between the HPG and HPA axes where gonadal steroids
are postulated to induce a negative feedback loop in HPA reactivity
(85). Gonadal steroids have also been theorized to stimulate oxy-
tocin and in turn promote maternal behaviors in the postpartum
period among mammals (86), as well as modulate immune and
autoimmune response in general (87, 88). A dual systems approach
that examines associative relations among two or more hormonal
outputs (e.g., cortisol, oxytocin, SIgA) holds great promise for a
deeper understanding of hormonal coaction during the antepar-
tum and postpartum periods as well as calibration of early gonadal
steroid activity in neonates and infants.
Typically, examination of relationships between two contin-
uous variables involves the use of a summary statistic, such
as a correlation; however, this is not always the most advan-
tageous method. Nagin and Tremblay (89) used a model that
jointly estimates growth mixture models for two distinct but
related measurement series. The joint probabilities generated
allow investigators to characterize the relationship between two
dependent variables as they unfold over a specified period of
time. Physiological attunement between members of the mother–
child dyad appears to be a worthwhile application for this dual
trajectory model.
CONCLUSION
Parturition marks a host of physiological adaptations associated
with changing environments; systems of respiration, circulation,
homeostasis, and state regulation are just a few examples. While
widely acknowledged that endocrine factors play an important
role in this transition, the interrelationship of mother and infant
gonadal steroids during this transition is not well understood.
Beyond organizational effects, we know even less about how the
transient activation of gonadal steroids in early postnatal life serves
to differentiate child behavior and development.
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As prenatal and neonatal gonadal steroid exposure can be
reliably ascertained from saliva, and collected in a non-invasive
manner particularly well-suited for research designs involving
neonates and infants, oral fluid may become the biospecimen of
choice for students of early human development. The purpose
of this review was to provide a conceptual and tactical roadmap
for investigators interested in integrating these measurement tools
surrounding saliva into research on gonadal steroid exposure and
health and human development. We continue to believe that the
implications of the information divulged via this research will have
a profound impact on developmental science in general, and the
study of neonatal health and development in particular.
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